51 GOP Senators Urge HHS, FDA to Restrict Abortion Drug

Fifty-one Republican senators have called on the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) to take immediate action to halt the distribution of mifepristone, an abortion pill, which they claim poses significant health risks to women. The letter, sent on Thursday, comes in the wake of the Biden administration's recent decision to allow mail-order prescriptions for the drug, a move the senators argue undermines state laws and endangers women's health.

The senators' request follows a lawsuit filed by Louisiana Attorney General Liz Murrill and a woman who survived complications from mifepristone, demanding the FDA revoke the mail-order permissions. The FDA had previously approved mifepristone 25 years ago but is now conducting a safety review of the drug, which critics say was approved without adequate safety considerations.

In their letter, the senators pointed to the removal of certain safeguards, such as the requirement for an in-person visit, as factors that have allowed the drug to be accessed by individuals who may misuse it, including minors and traffickers. They stated, "Every month, thousands of abortion drugs are shipped into states that have otherwise limited access to abortion after Dobbs, degrading pro-life laws at the state level across the country." (Lgraham Senate)

The letter also criticized the FDA's recent approval of a generic version of mifepristone, suggesting that the timing of this decision is inconsistent with the ongoing safety reassessment. They urged the FDA to halt the approval of any new generic versions of the drug until the safety review is complete.

Senator John Kennedy, who signed the letter, expressed concerns about the data used to support the drug's safety. He stated during a Senate Finance Committee meeting on September 4 that the Biden administration "actually twisted the data to bury one of the [mifepristone] safety signals." (Lgraham Senate)

Supporters of the senators' position, including Doug Truax, Founder and CEO of the Restoration of America Foundation, emphasized the urgency of the matter. Truax remarked, "We are heartened that 51 U.S. Senators recognize the extreme danger mifepristone poses to women across America and that immediate action is required. There is no time to wait — this is a health emergency." (Lgraham Senate)

The senators also highlighted alarming statistics regarding the drug's safety. Research from the Restoration of America Foundation indicates that more than one in ten women who take mifepristone experience serious adverse events, with life-threatening complications occurring at rates significantly higher than reported by the FDA and the drug's manufacturer, Danco Laboratories.

Critics of the senators' stance argue that restricting access to mifepristone could limit women's reproductive choices and access to safe medical care. Marjorie Dannenfelser, President of SBA Pro-Life America, stated, "Abortion drugs should be off the market completely in order to protect women and babies, but let’s start by restoring safeguards eviscerated by the Biden regime." (Lgraham Senate)

The letter from the Republican senators underscores a growing divide in the ongoing debate over abortion access and regulation in the United States. As states grapple with varying laws following the Supreme Court's decision in Dobbs v. Jackson Women's Health Organization, the future of mifepristone and similar medications remains a contentious issue.

The senators concluded their letter by urging the FDA to classify mifepristone as an "imminent hazard" (Lgraham Senate) and to prohibit its distribution until a thorough review is conducted. They believe that the agencies have sufficient information to reassess the drug's safety and efficacy, reflecting a broader concern about the implications of the current administration's policies on women's health and state rights.